Screening for HIV: ratios, risks and rationality.
Screening patients or healthcare workers for Human Immunodeficiency Virus is unlikely to be cost-effective if the benefit is seen only as the prevention of infection of one group by the other within the healthcare institution. Overwhelmingly, the benefit of screening comes from interrupting the chains of infection within the ongoing epidemic in the population at large.
Jones
M E
ME
School of Medicine , Flinders University, Adelaide, Australia.
D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000517:prevention & control; D004196:Disease Outbreaks / Q000517:prevention & control; D015658:HIV Infections / Q000191:economics / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D017757:Infectious Disease Transmission, Professional-to-Patient; D008403:Mass Screening / Q000191:economics; D009784:Occupational Diseases / Q000517:prevention & control; D012307:Risk Factors; D016635:Universal Precautions